|
|
|
|
|
by cdjk
1625 days ago
|
|
>>Vaccines still lower disease severity.
>Not for kids under 5. That's why it's not approved. Wrong. Per the Pfizer press release [0], the immunogenicity analysis of the trial failed in children ages 2 to 4, but succeeded in children ages six months to two years. Given the small dose (3ug) in that study cohort, there was probably not enough rna in the vaccine for the 2-4 age group to show any effect. >Why is this a valid concern, but potential long-term effects of the vaccines aren't? Especially the known risk of inflammation in still-growing bodies and especially in developing hearts. The risk of developing myocarditis from the vaccine is about 100-150 in 5 million [1]. The risk of developing myocarditis from COVID-19 is about 150 in 100,000 [2]. I know I'm picking the vaccine for my child. [0] https://www.pfizer.com/news/press-release/press-release-deta...
[1] https://www.nature.com/articles/d41586-021-02740-y
[2] https://www.cdc.gov/mmwr/volumes/70/wr/mm7035e5.htm edited for typos. |
|
I’m all for getting kids vaccinated when it’s deemed safe and effective (my daughter got vaccinated the first week it was available). But the risk to kids is quite low.